{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-061445","form_type":"8-K","ticker":"VTGN","cik":"0001411685","company_name":"Vistagen Therapeutics, Inc.","filed_at":"2026-09-10T23:24:47+00:00","discovered_at":"2026-09-11T10:05:00.807295+00:00","generated_at":"2026-09-11T10:05:29.917582+00:00","sec_items":["5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Vistagen shareholders elect board, back say-on-pay and KPMG at annual meeting","bullets":["All four director nominees elected: Saxe, Cunningham, Williamson, Singh; Cunningham and Singh saw narrower support (4.66M/3.83M and 4.97M/3.53M).","Say-on-pay advisory vote approved: 6,625,045 for, 1,142,430 against, 729,413 abstentions.","KPMG LLP ratification approved as FY2027 auditor: 22,495,649 for, 680,897 against, 685,683 abstentions."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-061445","json":"https://secwatch.observer/filing/0001628280-26-061445.json","markdown":"https://secwatch.observer/filing/0001628280-26-061445.md","text":"https://secwatch.observer/filing/0001628280-26-061445.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1411685/000162828026061445/0001628280-26-061445-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1411685/000162828026061445/vtgn-20260910.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-11T10:05:29.917582+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}